What Are the Differences Between Squamous Cell Carcinoma and Adenocarcinoma?

When it comes to cancer, most people sigh with concern—after all, all cancers are potentially life-threatening. Once diagnosed, a patient’s quality of life typically declines significantly, and the risk of mortality becomes ever-present. Squamous cell carcinoma (SCC) and adenocarcinoma are two such malignancies. Although both share the designation “carcinoma,” they differ in nomenclature, origin, behavior, and clinical management—and thus require distinct diagnostic and therapeutic approaches. So, what are the key differences between squamous cell carcinoma and adenocarcinoma? Below, we address this question.

What Are the Differences Between Squamous Cell Carcinoma and Adenocarcinoma?

Squamous cell carcinoma and adenocarcinoma are two of the most common histopathological types of cancer encountered clinically. Both arise from epithelial cells and are classified as malignant tumors. However, notable differences exist in their clinical behavior. Clinically, adenocarcinoma tends to exhibit faster tumor growth compared with squamous cell carcinoma, which generally progresses more slowly. Moreover, adenocarcinoma frequently metastasizes early in its course, whereas squamous cell carcinoma more commonly presents initially with local tissue invasion, with distant metastasis occurring relatively later. Furthermore, treatment strategies differ: because adenocarcinoma often disseminates systemically, systemic therapies (e.g., chemotherapy, targeted therapy, or immunotherapy) are frequently employed. In contrast, squamous cell carcinoma is predominantly locally invasive in its earlier stages, with distant metastasis typically emerging only in advanced disease; therefore, localized treatments (e.g., surgery or radiation therapy) are usually prioritized upon diagnosis. Thus, significant distinctions exist between the two in terms of therapeutic approach.

Knowledge Extension: Symptoms of Squamous Cell Carcinoma

1. Papillomatous (Cauliflower-like) Type

This type initially manifests as an infiltrative small plaque, nodule, or ulcer, subsequently developing into a raised, papillomatous, or cauliflower-like lesion. The color ranges from light red to dark red; the base is broad and firm. Dilated capillaries may be visible on the surface, along with scaling and crusting. The apex often displays spiky, keratotic projections. Forced removal of the crust typically results in bleeding from the base. This variant is most commonly observed on the face and extremities. Additionally, early lesions on the lower eyelid often appear as localized small nodules, which may be papillomatous or nodular; pigmentary changes occur in a minority of cases.

2. Ulcerative Type

The ulcer in this type is large and deep, with an irregular, crater-like base resembling a volcanic caldera. Its margins are elevated and everted. This variant exhibits rapid progression and a high propensity for early regional lymph node metastasis. In advanced stages, the tumor extends both superficially across the eyelid and its surrounding tissues, and deeply into the eyelid structures. Ultimately, it may invade the globe itself, destroying ocular and orbital tissues—and even extend intracranially. Secondary infection or hemorrhage may occur, leading to anemia and cancer-related cachexia, culminating in fatal deterioration.

The above outlines the principal differences between squamous cell carcinoma and adenocarcinoma. We hope this information proves helpful.